These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1349812)

  • 1. Inhibition of synthesis of endothelium-derived nitric oxide in conscious dogs. Hemodynamic, renal, and hormonal effects.
    Elsner D; Müntze A; Kromer EP; Riegger GA
    Am J Hypertens; 1992 May; 5(5 Pt 1):288-91. PubMed ID: 1349812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of L-NG-nitro-arginine, inhibitor of nitric oxide synthesis, on autoregulation of renal blood flow in dogs.
    Kiyomoto H; Matsuo H; Tamaki T; Aki Y; Hong H; Iwao H; Abe Y
    Jpn J Pharmacol; 1992 Feb; 58(2):147-55. PubMed ID: 1507520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional hemodynamics after chronic nitric oxide inhibition in spontaneously hypertensive rats.
    Varagic J; Jerkic M; Jovovic D; Nastic-Miric D; Adanja-Grujic G; Markovic-Lipkovski J; Lackovic V; Radujkovic-Kuburovic G; Kentera D
    Am J Med Sci; 2000 Sep; 320(3):171-6. PubMed ID: 11014370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect on renin release of inhibiting renal nitric oxide synthesis in anaesthetized dogs.
    Naess PA; Christensen G; Kirkebøen KA; Kiil F
    Acta Physiol Scand; 1993 Jun; 148(2):137-42. PubMed ID: 8352025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of nitric oxide in long-term angiotensin II-induced renal vasoconstriction.
    Manning RD; Hu L; Mizelle HL; Granger JP
    Hypertension; 1993 Jun; 21(6 Pt 2):949-55. PubMed ID: 8505105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular actions of inhibitors of endothelium-derived relaxing factor (nitric oxide) formation/release in anesthetized dogs.
    Klabunde RE; Ritger RC; Helgren MC
    Eur J Pharmacol; 1991 Jun; 199(1):51-9. PubMed ID: 1893927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelium-derived relaxing factor in regulation of basal cardiopulmonary and renal function.
    Perrella MA; Hildebrand FL; Margulies KB; Burnett JC
    Am J Physiol; 1991 Aug; 261(2 Pt 2):R323-8. PubMed ID: 1877690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of endothelium-derived relaxing factor in the in vivo renal vascular action of adenosine in dogs.
    Okumura M; Miura K; Yamashita Y; Yukimura T; Yamamoto K
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1262-7. PubMed ID: 1545391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of NG-nitro-L-arginine on renal hemodynamic responses to endothelin-3 in anesthetized dogs.
    Yamashita Y; Yukimura T; Miura K; Okumura M; Yamanaka S; Yamamoto K
    J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S332-4. PubMed ID: 1725372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic vasoconstriction induced by inhibition of nitric oxide synthesis is attenuated in conscious dogs with heart failure.
    Elsner D; Müntze A; Kromer EP; Riegger GA
    Cardiovasc Res; 1991 May; 25(5):438-40. PubMed ID: 1855247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of blood flow autoregulation plateau during nitric oxide blockade in canine kidney.
    Majid DS; Navar LG
    Am J Physiol; 1992 Jan; 262(1 Pt 2):F40-6. PubMed ID: 1733296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of endothelium-derived nitric oxide on renal hemodynamics and function in the sheep fetus.
    Bogaert GA; Kogan BA; Mevorach RA
    Pediatr Res; 1993 Dec; 34(6):755-61. PubMed ID: 8108188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms involved in the cardiovascular-renal actions of nitric oxide inhibition.
    Manning RD; Hu L; Williamson TD
    Hypertension; 1994 Jun; 23(6 Pt 2):951-6. PubMed ID: 8206634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Halothane impairs the hemodynamic influence of endothelium-derived nitric oxide.
    Sigmon DH; Florentino-Pineda I; Van Dyke RA; Beierwaltes WH
    Anesthesiology; 1995 Jan; 82(1):135-43. PubMed ID: 7832295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of EDRF in the regulation of regional blood flow and vascular resistance at rest and during exercise in conscious dogs.
    Shen W; Lundborg M; Wang J; Stewart JM; Xu X; Ochoa M; Hintze TH
    J Appl Physiol (1985); 1994 Jul; 77(1):165-72. PubMed ID: 7525527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal responses to intra-arterial administration of nitric oxide donor in dogs.
    Majid DS; Williams A; Kadowitz PJ; Navar LG
    Hypertension; 1993 Oct; 22(4):535-41. PubMed ID: 8406658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of nitric oxide in the arterial pressure and renal adaptations to long-term changes in sodium intake.
    Manning RD; Hu L; Reckelhoff JF
    Am J Physiol; 1997 Apr; 272(4 Pt 2):R1162-9. PubMed ID: 9140016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular-renal responses to long-term nitric oxide inhibition during angiotensin II-AT1 receptor inhibition.
    Manning RD; Hu L
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):328-39. PubMed ID: 9544874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal effects of prolonged synthesis inhibition of endothelium-derived nitric oxide.
    Salazar FJ; Pinilla JM; López F; Romero JC; Quesada T
    Hypertension; 1992 Jul; 20(1):113-7. PubMed ID: 1618546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of nitric oxide synthesis attenuates pressure-induced natriuretic responses in anesthetized dogs.
    Majid DS; Williams A; Navar LG
    Am J Physiol; 1993 Jan; 264(1 Pt 2):F79-87. PubMed ID: 8430833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.